Pepscope Secures €4.3 million Investment to Develop and Commercialize QuantaKinome

Utrecht Holdings is happy to see that Pepscope BV has managed to attract a major investment to further develop its proprietary QuantaKinome™ platform towards patient benefit.

The QuantaKinome™ technology has been invented by the group of Maarten Altelaar, professor in Pharmaceutical Proteomics at the Department of Pharmaceutical Sciences of the Utrecht University. The technology was patented by Utrecht Holdings and licensed to Pepscope BV. Pepscope and Altelaar’s research group collaborate to further develop innovative technologies for kinase profiling.

press release: